BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

852 related articles for article (PubMed ID: 19515018)

  • 41. Molecular biology of hepatitis C infection.
    Drazan KE
    Liver Transpl; 2000 Jul; 6(4):396-406. PubMed ID: 10915159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of lipid rafts in hepatitis C virus life cycle].
    Grek M; Bartkowiak J; Sidorkiewicz M
    Postepy Biochem; 2007; 53(4):334-43. PubMed ID: 19024898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication.
    Carrière M; Pène V; Breiman A; Conti F; Chouzenoux S; Meurs E; Andrieu M; Jaffray P; Grira L; Soubrane O; Sogni P; Calmus Y; Chaussade S; Rosenberg AR; Podevin P
    J Med Virol; 2007 Feb; 79(2):155-60. PubMed ID: 17177304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The role of hepatitis C virus RNA detection in various substrates of patients with chronic hepatitis C].
    Iushchuk ND; Klimofa EA; Znoĭko OO; Pyleva OG; Kelli EI; Cheshik DS; Braginskiĭ DM; Lakina EI; Masalova OV; Kushch AA
    Klin Med (Mosk); 2001; 79(12):24-8. PubMed ID: 11840806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C virus core protein, lipid droplets and steatosis.
    Roingeard P; Hourioux C
    J Viral Hepat; 2008 Mar; 15(3):157-64. PubMed ID: 18086178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes.
    Ferraris P; Blanchard E; Roingeard P
    J Gen Virol; 2010 Sep; 91(Pt 9):2230-7. PubMed ID: 20484561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
    Gottwein JM; Bukh J
    Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatitis C virus as a causative agent of carcinogenesis--recent trends for study].
    Kato N
    Nihon Rinsho; 1997 Nov; 55(11):3051-62. PubMed ID: 9396312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell entry of hepatitis C virus.
    Bartosch B; Cosset FL
    Virology; 2006 Apr; 348(1):1-12. PubMed ID: 16455127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of the hepatitis C virus replication complex.
    Brass V; Gosert R; Moradpour D
    Methods Mol Biol; 2009; 510():195-209. PubMed ID: 19009263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intra-host genetic heterogeneity of hepatitis C virus and biomedical implications.
    Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):120-4. PubMed ID: 14518708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. c-Fos regulates hepatitis C virus propagation.
    Kang SM; Lim S; Won SJ; Shin YJ; Lim YS; Ahn BY; Hwang SB
    FEBS Lett; 2011 Oct; 585(20):3236-44. PubMed ID: 21920361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of steroids on hepatitis C virus replication in vivo and in vitro.
    Henry SD; Metselaar HJ; Van Dijck J; Tilanus HW; Van Der Laan LJ
    Ann N Y Acad Sci; 2007 Sep; 1110():439-47. PubMed ID: 17911459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Virology of hepatitis C virus].
    Hofmann H
    Wien Med Wochenschr; 2000; 150(23-24):463-6. PubMed ID: 11205175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical consequences of hepatitis C virus infection.
    Zoulim F; Chevallier M; Maynard M; Trepo C
    Rev Med Virol; 2003; 13(1):57-68. PubMed ID: 12516062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitation of replication of the HCV genome in human livers with end-stage cirrhosis by strand-specific real-time RT-PCR assays: methods and clinical relevance.
    Lin L; Libbrecht L; Verbeeck J; Verslype C; Roskams T; van Pelt J; Van Ranst M; Fevery J
    J Med Virol; 2009 Sep; 81(9):1569-75. PubMed ID: 19626615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
    Inokuchi M; Ito T; Uchikoshi M; Shimozuma Y; Morikawa K; Nozawa H; Shimazaki T; Hiroishi K; Miyakawa Y; Imawari M
    J Med Virol; 2009 Apr; 81(4):619-27. PubMed ID: 19235854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
    Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
    Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular methods of hepatitis C genotyping.
    Weck K
    Expert Rev Mol Diagn; 2005 Jul; 5(4):507-20. PubMed ID: 16013969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.
    Kang JI; Kwon SN; Park SH; Kim YK; Choi SY; Kim JP; Ahn BY
    Virus Res; 2009 Jun; 142(1-2):51-6. PubMed ID: 19189853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.